Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

MSLN (Mesothelin)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

VENTANA MSLN (SP74) ASSAY

VENTANA MSLN (SP74) ASSAY

›

MSLN positive	Mesothelioma	MSLN positive	Mesothelioma	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2
MSLN expression	Lung Cancer	MSLN expression	Lung Cancer	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2
MSLN expression	Ovarian Cancer	MSLN expression	Ovarian Cancer	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2
MSLN expression	Mesothelioma	MSLN expression	Mesothelioma	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2	TC-210 Sensitive: C2 – Inclusion Criteria TC-210 Sensitive : C2
MSLN expression	Solid Tumor	MSLN expression	Solid Tumor	BAY 94-9343 Sensitive: C2 – Inclusion Criteria BAY 94-9343 Sensitive : C2	BAY 94-9343 Sensitive: C2 – Inclusion Criteria BAY 94-9343 Sensitive : C2
MSLN positive	Solid Tumor	MSLN positive	Solid Tumor	T-lymphocyte cell therapy Sensitive: C3 – Early Trials T-lymphocyte cell therapy Sensitive : C3	T-lymphocyte cell therapy Sensitive: C3 – Early Trials T-lymphocyte cell therapy Sensitive : C3
MSLN overexpression	Ovarian Cancer	MSLN overexpression	Ovarian Cancer	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3
MSLN overexpression	Malignant Pleural Mesothelioma	MSLN overexpression	Malignant Pleural Mesothelioma	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3	TC-210 Sensitive: C3 – Early Trials TC-210 Sensitive : C3
MSLN expression	Pancreatic Cancer	MSLN expression	Pancreatic Cancer	T-lymphocyte cell therapy Sensitive: C4 – Case Studies T-lymphocyte cell therapy Sensitive : C4	T-lymphocyte cell therapy Sensitive: C4 – Case Studies T-lymphocyte cell therapy Sensitive : C4
MSLN overexpression + TP53 mutation	Ovarian Cancer	MSLN overexpression + TP53 mutation	Ovarian Cancer	TC-210 Sensitive: C4 – Case Studies TC-210 Sensitive : C4	TC-210 Sensitive: C4 – Case Studies TC-210 Sensitive : C4
MSLN expression	Ovarian Cancer	MSLN expression	Ovarian Cancer	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4
MSLN expression	Pancreatic Cancer	MSLN expression	Pancreatic Cancer	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4	RG7600 Sensitive: C4 – Case Studies RG7600 Sensitive : C4